![Garth Lees-Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garth Lees-Rolfe
Director/Miembro de la Junta en
LUDWIG ENTERPRISES, INC.
.
Perfil
Mr. Garth Lees-Rolfe, CPA, is an Independent Director at Ludwig Enterprises, Inc. He is on the Board of Directors at Ludwig Enterprises, Inc. Mr. Lees-Rolfe was previously employed as a Chief Financial & Accounting Officer by Inhibikase Therapeutics, Inc. and a Vice President-Finance by F-star Therapeutics, Inc. He received his undergraduate degree from Queensland University of Technology.
Cargos activos de Garth Lees-Rolfe
| Empresas | Cargo | Inicio |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Director/Miembro de la Junta | 23/06/2025 |
Antiguos cargos conocidos de Garth Lees-Rolfe.
| Empresas | Cargo | Fin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director Financiero/CFO | 11/04/2025 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Formación de Garth Lees-Rolfe.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
19
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
 Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
- Bolsa de valores
- Insiders
- Garth Lees-Rolfe
